Deltex Medical > UK News

UK News

New Review: Importance of Haemodynamic Management in Avoiding AKI in Surgery

Acute Kidney Injury(AKI) is a major contributor to adverse surgical outcomes. Multiple publications point to peri‐operative AKI’s association with short‐ and long‐term complications, longer hospital stay, premature chronic kidney disease…

Deltex Medical Ltd. (UK) signs exclusive distribution agreement with Pacific Medical Systems Ltd. (Hong Kong).

Deltex Medical is a global technology leader in the field of haemodynamic management. Its oesophageal Doppler monitoring (ODM) system is supported by an unparalleled number of Randomised Controlled Trials (RCTs)…

Study Says Fluid Management is “Single Factor to Inform about AKI”

It’s broadly accepted that the risk of Acute Kidney Injury (AKI) risk in general surgery is about 8%. Accurate intraoperative fluid monitoring provides clinicians with an important tool that helps…

Deltex “Celebrating Success” in Edinburgh on Friday

This Friday (Nov 22nd) sees Deltex Medical heading to Edinburgh to participate in “Celebrating Success in Perioperative Care.” The event, held under the auspices of The Enhanced Recovery after Surgery Society…

Fill the Tank, Optimise Flow, Maintain Pressure: Interview at ASA Congress

Anesthesiology 2019 (#ANES19), which took place last weekend in Orlando, was also the venue for an interview with top anaesthesiologist, Prof. Michael Scott from Virginia Commonwealth University (VCU) Hospital. Click…

Deltex Heading to ASA with a Spring in its Step

Buoyed by a raft of recent good news, Deltex Medical is once again exhibiting at the forthcoming Anesthesiology Society of America (ASA) annual congress in Orlando, Florida. The event takes…

Innovate UK Smart Award

Deltex Medical Group plc (AIM: DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”) has announced that its wholly owned UK subsidiary, Deltex Medical Limited, has been awarded a grant…

Deltex Medical Receives Innovative Technology Contract From Major US Healthcare Consultancy

Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring, has received an Innovative Technology contract from Vizient, Inc., the largest member-driven healthcare performance improvement company in the…

Oesophageal Doppler Features Strongly in Updated Cancer Surgery Guidance

The UK’s National Institute for Health and Care Excellence (NICE) has updated its guidance for practitioners in the management of colorectal cancer. NICE publishes it’s so-called “pathways” in order to…

Deltex Medical’s Haemodynamic Management Tools at Euroanaesthesia

This weekend sees Vienna hosting the annual Euroanaesthesia event, recognised worldwide as one of the most important and influential congresses in anaesthesiology. With over 6000 international delegates and 100+ exhibitors from…

Terminus Road | Chichester | PO19 8TX | United Kingdom

  • Enquiries: +44 1243 774837
  • Email: marketing@deltexmedical.com
  • Deltex App:

 

Registered in England & Wales Company No: 1691369